ACAD

MKT CAP:$4B

ACADIA Pharmaceuticals Inc

Market Cap

$4B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$21.70-$4.59 (-17.46%)

Jun 8, 2026

52W High $28.0652W Low $20.06

Company Details

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin in...

CEO

—

IPO Date

May 27, 2004

Website

www.acadia.com

Key Metrics TTM

Revenue

$1.1B

+9.9% YoY

Net Income

$376M

EPS (Diluted)

Free Cash Flow

$212M

Revenue / Share

$6.34

Gross Margin

91.5%

Operating Margin

7.4%

Net Margin

34.3%

FCF Margin

19.4%

P/S

3.4x

P/E

9.8x

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

May 7, 2026

$268M+9.7%

FY 2025

Feb 25, 2026

$1.1B+11.9%

Q4 2025

Feb 25, 2026

$284M+9.4%

Q3 2025

Nov 6, 2025

$279M+11.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee